---
figid: PMC9359065__in9-4-e00007-g001
figtitle: PERK promotes immunosuppressive M2 macrophage phenotype by metabolic reprogramming
  and epigenetic modifications through the PERK-ATF4-PSAT1 axis
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
- Mus musculus
- Danio rerio
pmcid: PMC9359065
filename: in9-4-e00007-g001.jpg
figlink: /pmc/articles/PMC9359065/figure/F1/
number: F1
caption: 'A schematic presentation of critical role of PERK in metabolic reprogramming
  of macrophages via epigenetic changes. (A) IL-4 stimulation to WT macrophages results
  in activation of immunosuppressive M2 macrophage via SBP. (B) IL-4 stimulation to
  PERKcKO macrophages or PSAT1cKO macrophages results in alteration in SBP, which
  is responsible to drive the immunosuppressive epigenetic modifications in M2 macrophages.
  (C) Treatment of mice with GSK2656157 (PERK inhibitor) or NCT-503 (PHGDH inhibitor)
  reduce tumor burden as a monotherapy and combination therapy of AntiPD1 + GSK2656157
  potentiate the antitumor response. PERK: protein kinase RNA-like ER kinase; SBP:
  serine biosynthesis pathway.'
papertitle: PERK promotes immunosuppressive M2 macrophage phenotype by metabolic reprogramming
  and epigenetic modifications through the PERK-ATF4-PSAT1 axis.
reftext: Uday P. Pratap, et al. Immunometabolism (Cobham). 2022 Jul;4(3):e00007-e00007.
year: '2022'
doi: 10.1097/IN9.0000000000000007
journal_title: Immunometabolism (Cobham (Surrey, England)
journal_nlm_ta: Immunometabolism (Cobham)
publisher_name: Lippincott Williams & Wilkins
keywords: endoplasmic reticulum | ER stress | protein kinase RNA-like ER kinase |
  M2 macrophage | tumor-associated macrophages | myeloid cell-derived suppressor cells
automl_pathway: 0.8906603
figid_alias: PMC9359065__F1
figtype: Figure
redirect_from: /figures/PMC9359065__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9359065__in9-4-e00007-g001.html
  '@type': Dataset
  description: 'A schematic presentation of critical role of PERK in metabolic reprogramming
    of macrophages via epigenetic changes. (A) IL-4 stimulation to WT macrophages
    results in activation of immunosuppressive M2 macrophage via SBP. (B) IL-4 stimulation
    to PERKcKO macrophages or PSAT1cKO macrophages results in alteration in SBP, which
    is responsible to drive the immunosuppressive epigenetic modifications in M2 macrophages.
    (C) Treatment of mice with GSK2656157 (PERK inhibitor) or NCT-503 (PHGDH inhibitor)
    reduce tumor burden as a monotherapy and combination therapy of AntiPD1 + GSK2656157
    potentiate the antitumor response. PERK: protein kinase RNA-like ER kinase; SBP:
    serine biosynthesis pathway.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IL4
  - EIF2AK3
  - ATF4
  - PSAT1
  - PHGDH
  - MICE
  - Il4
  - Eif2ak3
  - Lamp1
  - Atf4
  - Psat1
  - Phgdh
  - Casp14
  - il4
  - il13
  - atf4a
  - acvr1ba
  - psat1
  - phgdh
---
